
John D. Pak
Examiner (ID: 5837, Phone: (571)272-0620 , Office: P/1616 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 2899, 1616, 1209, 1699, 1621 |
| Total Applications | 2719 |
| Issued Applications | 1510 |
| Pending Applications | 255 |
| Abandoned Applications | 976 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17444229
[patent_doc_number] => 20220064734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => GENETIC MARKER FOR HELICOBACTER PYLORIASSOCIATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/418609
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418609 | GENETIC MARKER FOR HELICOBACTER PYLORIASSOCIATED DISEASE | Dec 26, 2019 | Pending |
Array
(
[id] => 17520786
[patent_doc_number] => 20220106635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => METHOD FOR MEASURING TELOMERE ASSOCIATED VARIABLES AND USES THEREOF FOR THE DIAGNOSIS AND/OR PROGNOSIS OF TELOMERIC-ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/312262
[patent_app_country] => US
[patent_app_date] => 2019-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/312262 | METHOD FOR MEASURING TELOMERE ASSOCIATED VARIABLES AND USES THEREOF FOR THE DIAGNOSIS AND/OR PROGNOSIS OF TELOMERIC-ASSOCIATED DISEASES | Dec 23, 2019 | Pending |
Array
(
[id] => 17595813
[patent_doc_number] => 20220145387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHOD TO GENERATE BIOCOMPATIBLE DENDRITIC POLYMERS FOR ANALYTE DETECTION WITH MULTIMODAL LABELING AND SIGNAL AMPLIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/415586
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415586 | METHOD TO GENERATE BIOCOMPATIBLE DENDRITIC POLYMERS FOR ANALYTE DETECTION WITH MULTIMODAL LABELING AND SIGNAL AMPLIFICATION | Dec 19, 2019 | Pending |
Array
(
[id] => 15713305
[patent_doc_number] => 20200103418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => DIAGNOSTIC AND THERAPEUTIC METHODS FOR IRAK4-MEDIATED DISORDERS AND CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/713638
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -92
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713638 | DIAGNOSTIC AND THERAPEUTIC METHODS FOR IRAK4-MEDIATED DISORDERS AND CONDITIONS | Dec 12, 2019 | Abandoned |
Array
(
[id] => 15741105
[patent_doc_number] => 20200109440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => METHODS AND COMPOSITIONS FOR PREPARING RNA FROM A FIXED SAMPLE
[patent_app_type] => utility
[patent_app_number] => 16/712102
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712102
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712102 | METHODS AND COMPOSITIONS FOR PREPARING RNA FROM A FIXED SAMPLE | Dec 11, 2019 | Abandoned |
Array
(
[id] => 16204871
[patent_doc_number] => 20200237861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/703745
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16703745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/703745 | METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF | Dec 3, 2019 | Abandoned |
Array
(
[id] => 15713267
[patent_doc_number] => 20200103399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => METHODS FOR RARE EVENT DETECTION
[patent_app_type] => utility
[patent_app_number] => 16/701688
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16701688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/701688 | METHODS FOR RARE EVENT DETECTION | Dec 2, 2019 | Abandoned |
Array
(
[id] => 16223153
[patent_doc_number] => 20200248269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHODS FOR PREDICTING THE OUTCOME OF A CANCER IN A PATIENT BY ANALYSING GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 16/699784
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 95062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16699784
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/699784 | METHODS FOR PREDICTING THE OUTCOME OF A CANCER IN A PATIENT BY ANALYSING GENE EXPRESSION | Dec 1, 2019 | Abandoned |
Array
(
[id] => 17474223
[patent_doc_number] => 20220081727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => BIOMARKER FOR PREDICTING RESPONSE TO ANTICANCER AGENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/423929
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423929 | BIOMARKER FOR PREDICTING RESPONSE TO ANTICANCER AGENT AND USE THEREOF | Dec 1, 2019 | Abandoned |
Array
(
[id] => 17899475
[patent_doc_number] => 20220309137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => SECURITY MARKERS
[patent_app_type] => utility
[patent_app_number] => 17/309424
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309424 | SECURITY MARKERS | Nov 26, 2019 | Pending |
Array
(
[id] => 16269123
[patent_doc_number] => 20200270610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => OLIGONUCLEOTIDE PROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/694851
[patent_app_country] => US
[patent_app_date] => 2019-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 119884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16694851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/694851 | OLIGONUCLEOTIDE PROBES AND USES THEREOF | Nov 24, 2019 | Abandoned |
Array
(
[id] => 17357095
[patent_doc_number] => 20220017891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => IMPROVEMENTS IN VARIANT DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/295338
[patent_app_country] => US
[patent_app_date] => 2019-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295338
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295338 | IMPROVEMENTS IN VARIANT DETECTION | Nov 21, 2019 | Pending |
Array
(
[id] => 15867037
[patent_doc_number] => 20200140922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => Multiplex Detection of Nucleic Acids
[patent_app_type] => utility
[patent_app_number] => 16/683763
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16683763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/683763 | Multiplex Detection of Nucleic Acids | Nov 13, 2019 | Pending |
Array
(
[id] => 16362440
[patent_doc_number] => 20200319191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => MOLECULAR PROFILING FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/675488
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 112212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16675488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/675488 | MOLECULAR PROFILING FOR CANCER | Nov 5, 2019 | Abandoned |
Array
(
[id] => 17336459
[patent_doc_number] => 20220002790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => NUCLEIC ACID-BASED BARCODING
[patent_app_type] => utility
[patent_app_number] => 17/289889
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289889
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/289889 | NUCLEIC ACID-BASED BARCODING | Oct 31, 2019 | Pending |
Array
(
[id] => 15832569
[patent_doc_number] => 20200131566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => METHODS, COMPOSITIONS AND SYSTEMS FOR CALIBRATING EPIGENETIC PARTITIONING ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/670827
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16670827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/670827 | METHODS, COMPOSITIONS AND SYSTEMS FOR CALIBRATING EPIGENETIC PARTITIONING ASSAYS | Oct 30, 2019 | Abandoned |
Array
(
[id] => 17292579
[patent_doc_number] => 20210388418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => Method for Quantifying Molecular Activity in Cancer Cells of a Human Tumour
[patent_app_type] => utility
[patent_app_number] => 17/309055
[patent_app_country] => US
[patent_app_date] => 2019-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309055 | Method for Quantifying Molecular Activity in Cancer Cells of a Human Tumour | Oct 17, 2019 | Abandoned |
Array
(
[id] => 16328808
[patent_doc_number] => 20200299774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => MOLECULAR PROFILING FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/597061
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 140405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/597061 | MOLECULAR PROFILING FOR CANCER | Oct 8, 2019 | Abandoned |
Array
(
[id] => 15932003
[patent_doc_number] => 20200157635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/591813
[patent_app_country] => US
[patent_app_date] => 2019-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 114479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16591813
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/591813 | DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER | Oct 2, 2019 | Abandoned |
Array
(
[id] => 15742369
[patent_doc_number] => 20200110073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => RENAL DISEASE TARGETS
[patent_app_type] => utility
[patent_app_number] => 16/591278
[patent_app_country] => US
[patent_app_date] => 2019-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16591278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/591278 | RENAL DISEASE TARGETS | Oct 1, 2019 | Abandoned |